The Impact of the COVID-19 Pandemic on the Patient in Need of an Intervention
Launched by UNIVERSITY MEDICAL CENTER GRONINGEN · Feb 20, 2023
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how the COVID-19 pandemic affected patients in the Netherlands who needed surgery or other medical procedures during 2020 and 2021. Researchers want to understand how changes in healthcare during the pandemic impacted patients' quality of life and their experiences with medical care. The study has three phases: first, they will conduct focus groups to hear directly from patients about their experiences. Next, they will create a questionnaire based on what they learn. In the final phase, they will use this questionnaire to gather more information from patients who had surgeries or procedures during that time.
If you are a patient who had surgery or another medical intervention in the Netherlands during 2020 or 2021, you may be eligible to participate. The trial is open to all genders, but participants must be able to speak Dutch. By taking part in this study, you can share your experiences, which will help improve healthcare for future patients. The researchers will also compare your answers with national patient records to gain deeper insights. This is a great opportunity to contribute to important research that can lead to better patient care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • undergoing surgery or intervention in the Netherlands in 2020 or 2021
- Exclusion Criteria:
- • participation language restricted to Dutch
About University Medical Center Groningen
University Medical Center Groningen (UMCG) is a leading academic medical center in the Netherlands, renowned for its commitment to innovative research, high-quality patient care, and extensive education in the medical field. As a prominent sponsor of clinical trials, UMCG leverages its multidisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve therapeutic outcomes. The center fosters collaboration among researchers, healthcare professionals, and industry partners, aiming to translate scientific discoveries into effective treatments that enhance patient health and well-being. With a focus on ethical standards and regulatory compliance, UMCG is dedicated to conducting clinical trials that contribute to the advancement of medicine and the betterment of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Groningen, , Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials